Vertex Pharmaceuticals stock falls after pain drug fails in Phase 2 study
Firsthand Technology Value Fund, Inc., a publicly traded investment fund, disclosed the outcomes of its Annual Meeting of Stockholders held on May 21, 2025, in a recent 8-K filing with the Securities and Exchange Commission (SEC). The meeting, which involved shareholder voting on two key proposals, was attended in person or by proxy by holders of 5,186,854 shares, constituting a quorum from a total of 6,893,056 outstanding shares. The company’s stock has faced significant challenges, with a 62% decline over the past year and currently trading at $0.05, near its 52-week low of $0.04.
The first proposal concerned the election of directors. Shareholders elected Kimun Lee as a Class II director to serve on the board until the 2028 annual meeting or until his successor is elected. Lee received 905,257 votes in favor, with 2,858,531 withheld votes and 1,423,066 broker non-votes.
The second proposal was the ratification of the appointment of Tait, Weller & Baker LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2025. This proposal passed with 2,616,595 votes for and 2,565,830 votes against, with 4,428 abstentions and no broker non-votes.
Firsthand Technology Value Fund, Inc., based in San Jose, California, is listed on the OTC Markets under the ticker symbol SVVC. The fund specializes in investing in technology-related companies and products.
The company’s SEC filing provides these details without promotional commentary, ensuring that shareholders and the public are informed of the results of the Annual Meeting in a straightforward and factual manner. The information contained in this article is based solely on the press release statement provided by Firsthand Technology Value Fund, Inc.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.